• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种用于分析原料药和缓释制剂中异山梨醇单硝酸酯的经验证的高效液相色谱法。

A validated high performance liquid chromatographic method for analysis of isosorbide mononitrate in bulk material and extended release formulations.

作者信息

Verma Rajan K, Garg Sanjay

机构信息

Department of Pharmaceutics, National Institute of Pharmaceutical Education and Research, Sector 67, SAS Nagar, Punjab 160 062, India.

出版信息

J Pharm Biomed Anal. 2002 Oct 15;30(3):583-91. doi: 10.1016/s0731-7085(02)00317-5.

DOI:10.1016/s0731-7085(02)00317-5
PMID:12367683
Abstract

A reversed phase HPLC method using C(18) column was developed for the quantitative determination of isosorbide mononitrate (IMN) in the bulk material and extended release dosage forms. The method was specific to IMN and able to resolve the drug peak from the pharmacopoeial impurities and formulation excipients. The method was accurate, precise, and linear within the desired range. In addition to analysis of assay and dissolution samples, the method was successfully used for analysis of drug-excipient compatibility samples of IMN used for development of extended release formulations in our laboratory and their subsequent stability studies. The method was also used for analysis of IMN in commercially available raw material.

摘要

建立了一种使用C(18) 柱的反相高效液相色谱法,用于定量测定原料药和缓释剂型中的单硝酸异山梨酯(IMN)。该方法对IMN具有特异性,能够将药物峰与药典规定的杂质及制剂辅料峰分离。该方法在所需范围内准确、精密且呈线性。除了用于含量测定和溶出度样品的分析外,该方法还成功用于分析我们实验室中用于缓释制剂研发的IMN药物-辅料相容性样品及其后续稳定性研究。该方法还用于分析市售原料药中的IMN。

相似文献

1
A validated high performance liquid chromatographic method for analysis of isosorbide mononitrate in bulk material and extended release formulations.一种用于分析原料药和缓释制剂中异山梨醇单硝酸酯的经验证的高效液相色谱法。
J Pharm Biomed Anal. 2002 Oct 15;30(3):583-91. doi: 10.1016/s0731-7085(02)00317-5.
2
Compatibility studies between isosorbide mononitrate and selected excipients used in the development of extended release formulations.单硝酸异山梨酯与用于缓释制剂开发的选定辅料之间的相容性研究。
J Pharm Biomed Anal. 2004 May 28;35(3):449-58. doi: 10.1016/j.jpba.2004.01.012.
3
Determination of isosorbide dinitrate in pharmaceutical products by HPLC.高效液相色谱法测定药品中的硝酸异山梨酯
J Chromatogr Sci. 1988 Nov;26(11):574-8. doi: 10.1093/chromsci/26.11.574.
4
Simultaneous determination of aspirin and isosorbide 5-mononitrate in formulation by reversed phase high pressure liquid chromatography.采用反相高效液相色谱法同时测定制剂中阿司匹林和5-单硝酸异山梨酯的含量。
J Pharm Biomed Anal. 2003 Aug 21;32(6):1145-8. doi: 10.1016/s0731-7085(03)00248-6.
5
Gas chromatography-mass spectrometry determination of isosorbide 5-mononitrate and related impurities in raw materials and dosage formulations.气相色谱-质谱法测定原料药及制剂中5-单硝酸异山梨酯及其有关物质
J Pharm Biomed Anal. 1997 Nov;16(3):425-9. doi: 10.1016/s0731-7085(97)00079-4.
6
New methods for the assay of 5-isosorbide mononitrate and its validation.5-单硝酸异山梨酯的测定新方法及其验证
J Pharm Biomed Anal. 1991;9(9):725-9. doi: 10.1016/0731-7085(91)80213-s.
7
[Determination of isosorbide dinitrate and its degradation products in pharmaceuticals by gradient RP-HPLC].
Yao Xue Xue Bao. 1989;24(10):797-800.
8
Validation of high-performance liquid chromatographic methods for analysis of sustained-release preparations containing nitroglycerin, isosorbide dinitrate, or pentaerythritol tetranitrate.用于分析含硝酸甘油、硝酸异山梨酯或季戊四醇四硝酸酯的缓释制剂的高效液相色谱法的验证
J Pharm Sci. 1983 Feb;72(2):124-6. doi: 10.1002/jps.2600720207.
9
Gas-liquid chromatographic determination of isosorbide dinitrate in tablets.气相色谱法测定片剂中的硝酸异山梨酯
J Assoc Off Anal Chem. 1977 Nov;60(6):1341-4.
10
Development and evaluation of extended release formulations of isosorbide mononitrate based on osmotic technology.
Int J Pharm. 2003 Sep 16;263(1-2):9-24. doi: 10.1016/s0378-5173(03)00360-0.

引用本文的文献

1
Combined isosorbide dinitrate and ibuprofen as a novel therapy for muscular dystrophies: evidence from Phase I studies in healthy volunteers.联合使用硝酸异山梨酯和布洛芬作为治疗肌肉萎缩症的新疗法:来自健康志愿者一期研究的证据。
Drug Des Devel Ther. 2014 May 2;8:411-9. doi: 10.2147/DDDT.S58803. eCollection 2014.